201 related articles for article (PubMed ID: 26284286)
1. Creating New Economic Incentives for Repurposing Generic Drugs for Unsolved Diseases Using Social Finance.
Bloom BE
Assay Drug Dev Technol; 2015 Dec; 13(10):606-11. PubMed ID: 26284286
[TBL] [Abstract][Full Text] [Related]
2. The trials and tribulations of repurposing metformin and other generic drugs for tuberculosis.
Bloom BE
Pharm Pat Anal; 2016; 5(2):101-5. PubMed ID: 26889918
[TBL] [Abstract][Full Text] [Related]
3. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
4. Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government.
van der Pol KH; Aljofan M; Blin O; Cornel JH; Rongen GA; Woestelandt AG; Spedding M
Appl Health Econ Health Policy; 2023 Nov; 21(6):831-840. PubMed ID: 37398987
[TBL] [Abstract][Full Text] [Related]
5. The economics of pediatric formulation development for off-patent drugs.
Milne CP; Bruss JB
Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
[TBL] [Abstract][Full Text] [Related]
6. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
Menkes DB; Woodall AA
N Z Bioeth J; 2003 Oct; 4(3):22, 24-5. PubMed ID: 15597480
[No Abstract] [Full Text] [Related]
7. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
Woolner D
N Z Bioeth J; 2003 Oct; 4(3):22, 25-6. PubMed ID: 15597481
[No Abstract] [Full Text] [Related]
8. Perspectives on Drug Repurposing.
Schcolnik-Cabrera A; Juárez-López D; Duenas-Gonzalez A
Curr Med Chem; 2021; 28(11):2085-2099. PubMed ID: 32867630
[TBL] [Abstract][Full Text] [Related]
9. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
10. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
Grice S
N Z Bioeth J; 2003 Oct; 4(3):22-4. PubMed ID: 15597479
[No Abstract] [Full Text] [Related]
11. An Indian effort towards affordable drugs: "generic to designer drugs".
Taneja B; Yadav J; Chakraborty TK; Brahmachari SK
Biotechnol J; 2009 Mar; 4(3):348-60. PubMed ID: 19296440
[No Abstract] [Full Text] [Related]
12. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
Adams J
N Z Bioeth J; 2003 Oct; 4(3):22-3. PubMed ID: 15597478
[No Abstract] [Full Text] [Related]
13. The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?
Giovannoni G; Baker D; Schmierer K
Mult Scler Relat Disord; 2015 Jan; 4(1):3-5. PubMed ID: 25787047
[TBL] [Abstract][Full Text] [Related]
14. The roles of academia, rare diseases, and repurposing in the development of the most transformative drugs.
Kesselheim AS; Tan YT; Avorn J
Health Aff (Millwood); 2015 Feb; 34(2):286-93. PubMed ID: 25646109
[TBL] [Abstract][Full Text] [Related]
15. Pharmacies receiving massive rebates from generic drug-makers.
Silversides A
CMAJ; 2006 Aug; 175(4):342. PubMed ID: 16908889
[No Abstract] [Full Text] [Related]
16. Pharmaceuticals and medical devices: cost savings.
; Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843
[No Abstract] [Full Text] [Related]
17. Drug rediscovery to prevent off-label prescription reduces health care costs: the case of tioguanine in the Netherlands.
Mulder CJ; van Asseldonk DP; de Boer NK
J Gastrointestin Liver Dis; 2014 Jun; 23(2):123-5. PubMed ID: 24949602
[No Abstract] [Full Text] [Related]
18. Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity.
Power A; Berger AC; Ginsburg GS
JAMA; 2014 May; 311(20):2063-4. PubMed ID: 24867009
[No Abstract] [Full Text] [Related]
19. [More than "cheap copies". Generic drugs promote medical progress].
MMW Fortschr Med; 2004 Jun; 146(24):51. PubMed ID: 15366498
[No Abstract] [Full Text] [Related]
20. Generic medicines: solutions for a sustainable drug market?
Dylst P; Vulto A; Godman B; Simoens S
Appl Health Econ Health Policy; 2013 Oct; 11(5):437-43. PubMed ID: 23846572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
